KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Other financing activities (2016)

Historic Other financing activities for Globus Medical (GMED) over the last 6 years, with Q4 2016 value amounting to $116000.0.

  • Globus Medical's Other financing activities rose 10284.8% to $116000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $1.6 million, marking a year-over-year increase of 17619.05%. This contributed to the annual value of $1.6 million for FY2016, which is 17619.05% up from last year.
  • As of Q4 2016, Globus Medical's Other financing activities stood at $116000.0, which was up 10284.8% from $720000.0 recorded in Q3 2016.
  • Globus Medical's 5-year Other financing activities high stood at $109.3 million for Q2 2012, and its period low was -$4.1 million during Q4 2015.
  • Moreover, its 5-year median value for Other financing activities was $571500.0 (2015), whereas its average is $6.0 million.
  • Its Other financing activities has fluctuated over the past 5 years, first skyrocketed by 852333.33% in 2012, then tumbled by 121895.6% in 2015.
  • Globus Medical's Other financing activities (Quarter) stood at $17000.0 in 2012, then skyrocketed by 1294.12% to $237000.0 in 2013, then soared by 53.59% to $364000.0 in 2014, then tumbled by 1218.96% to -$4.1 million in 2015, then surged by 102.85% to $116000.0 in 2016.
  • Its last three reported values are $116000.0 in Q4 2016, $720000.0 for Q3 2016, and $254000.0 during Q2 2016.